Fort Point Capital Partners’s Avidity Biosciences RNAM Stock Holding History

Fort Point Capital Partners’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,778	Closed	-$1.51M	–	235
2025 Q4	$1.51M	Sell	20,778 -10,500	-34%	-$678K	0.17%	85
2025 Q3	$1.36M	Buy	31,278 +183	+0.6%	+$7.4K	0.16%	89
2025 Q2	$883K	Sell	31,095 -183	-0.6%	-$5.45K	0.06%	158
2025 Q1	$923K	Hold	31,278	–	–	0.1%	136
2024 Q4	$910K	Buy	+31,278	New	+$1.31M	0.1%	135

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Fort Point Capital Partners's RNAM Position: Q1 2026 in Review

Fort Point Capital Partners sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 20,778 shares — an estimated $1.51M sold.

Fort Point Capital Partners first reported a position in RNAM in Q4 2024 and held it in 5 quarters. The position peaked at $1.51M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Fort Point Capital Partners reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Fort Point Capital Partners sold 20,778 Avidity Biosciences shares in Q1 2026, an estimated $1.51M.
Fort Point Capital Partners first reported a position in Avidity Biosciences in Q4 2024 and held it in 5 quarters.
Fort Point Capital Partners's Avidity Biosciences position peaked at $1.51M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Fort Point Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.